BioSpace News Archive

Business

ImmunoMet Appoints Briggs W. Morrison, M.D., and Paul Lammers, M.D., M.Sc., to Board of Directors

Dr. Morrison currently serves as the CEO and is a member of the board of directors of Syndax.

November 28, 2017

·

4 min read

GenePOC Launches its GenePOC CDiff Test in the United States

GenePOC is proud to announce the launch of its 2nd FDA cleared assay in less than 6 months, GenePOC CDiff, for use on the revogene instrument.

November 28, 2017

·

5 min read

Aytu BioScience Provides Update on the Continued Growth of Natesto in the U.S.

Significant Natesto prescription growth continued through October 2017, with prescriptions increasing 17% from the previous month, reaching their highest levels to date.

November 28, 2017

·

5 min read

Business

Varian Partners With Penn Medicine for Proton Therapy Training and Education Program

The program will cover all aspects of proton therapy, from patient selection and planning through treatment and follow-up.

November 28, 2017

·

1 min read

Business

Charles River Announces Success of Integrated Discovery Project With ENYO Pharma

ENYO Pharma worked with scientists from Charles River to optimize a potent, novel chemical series (with unknown molecular target) for inhibition of Influenza replication.

November 28, 2017

·

4 min read

Business

Ironwood Appoints New COO and CFO

The company announced the appointment of William Huyett as COO and the promotion of Gina Consylman to senior vice president and CFO.

November 28, 2017

·

6 min read

TESARO Announces U.S. FDA Approval of VARUBI IV fo

Policy

PAVmed Files 510(k) Submission With FDA for CarpX Device to Treat Carpal Tunnel Syndrome

Designed to replace invasive surgery and shorten recovery time; addresses an estimated $1 billion market opportunity.

November 28, 2017

·

6 min read

Drug Development

ImmusanT Data Shows Up-Dosing Substantially Increases Nexvax2 Dose Levels That Are Safe and Tolerable, Further Supports Phase II Studies

This study demonstrates that gradually increasing the dose from a low, well-tolerated starting dose enables Nexvax2 to be safe and tolerable without dose-limiting adverse events at a level of 900 μg,.

November 28, 2017

·

5 min read

Business

Applied Photophysics Expands Management Team and Strengthens Sales and Application Support

The Company has also expanded its sales and scientific support teams across the US, UK and Germany with the addition of four Sales Managers and two more Application Scientists

November 28, 2017

·

3 min read

Drug Development

Takeda Initiates Phase I Clinical Trial of Zika Vaccine Candidate

The clinical trial (ZIK-101) will evaluate safety and immunogenicity of TAK-426 in 240 subjects between the ages of 18 and 49 across the continental U.S. and U.S. territories.

November 28, 2017

·

8 min read